In addition, the clinicopathologic characteristics such as age (Fig. 5A), gender (Fig. 5B), GTF2I mutation (Fig. 5C), histologic subtype (Fig. 5D), MG history (Fig. 5E) and Masaoka stage (Fig. 5F) also demonstrated that patients in the low-risk group had lower odds of tumor recurrence compared with the high-risk group. This evidence concerns the gene GTF2I and neoplasm.